High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Guerrero-Martínez, Jose A.
Reyes, Jose C.
Text and Data Mining valid from 2018-02-01
21 July 2017
16 January 2018
1 February 2018
The authors declare that they have no competing interests.